SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/refractory multiple myeloma (R/R MM) was presented in a poster at the 67th American Society of… Continue reading CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
Tag: Production/Sales News
Median PFS Trending Beyond One Year: Leads Biolabs’ LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ — From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology (“ASH”) was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company”, Stock Code: 9887.HK) delivered an oral presentation on the opening day of the conference featuring… Continue reading Median PFS Trending Beyond One Year: Leads Biolabs’ LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignancies and autoimmune diseases, announced the oral presentation of updated clinical data for its independently developed, fully human BCMA-targeted… Continue reading IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
Hydron Energy Demonstrates Low-Cost Production of Xenon with Negative Carbon Footprint for Satellite Propulsion
NORTH VANCOUVER, BC, Dec. 7, 2025 /PRNewswire/ – Hydron Energy, a leading innovator in clean fuel and gas separation technologies, today announced the successful demonstration of carbon-negative Xenon and Krypton production from air. The initiative focused on application of Hydron’s next generation metal-organic framework (MOF) in the company’s INTRUPTor™ gas separation platform for direct air… Continue reading Hydron Energy Demonstrates Low-Cost Production of Xenon with Negative Carbon Footprint for Satellite Propulsion
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 7, 2025 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known as monkeypox2). Mpox is a viral infectious disease that has been spreading in the Democratic Republic of the Congo (DRC) and… Continue reading Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration Opportunities BEIJING, Dec. 7, 2025 /PRNewswire/ — The 4th China International Supply Chain Expo (“CISCE,” “the Expo”) will be held in Beijing from June 22 to 26, 2026. To date, more than 300 companies have signed up to exhibit, with preparations moving forward smoothly. Continue Reading Canada-China Forum on… Continue reading The 4th China International Supply Chain Expo Set for Beijing in June 2026
Strutt ev¹ the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins
The awards-winning robotics company officially kicks off its pre-order window ahead of its main launch at CES 2026. SINGAPORE, Dec. 6, 2025 /PRNewswire/ — Strutt, a Singapore-incorporated robotics company advancing smart everyday vehicle, announced the opening of Super Early Bird access for the Strutt ev¹, the only product winning both 2026 CES Best of Innovation… Continue reading Strutt ev¹ the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/refractory multiple myeloma (R/R MM) was presented in a poster at the 67th American Society of… Continue reading CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
Global Times: Xi Jinping Thought on Economy guides long-term steady economic growth for China: Jin Sheping
BEIJING, Dec. 7, 2025 /PRNewswire/ — The 14th Five-Year Plan period (2021-25) was anything but ordinary – China’s economy has advanced steadily and reached new heights, fully demonstrating its distinctive advantages. Chinese President Xi Jinping has profoundly grasped the laws of economic development and the country’s overall situation. The Fourth Plenary Session of the 20th… Continue reading Global Times: Xi Jinping Thought on Economy guides long-term steady economic growth for China: Jin Sheping
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore
SINGAPORE, Dec. 7, 2025 /PRNewswire/ — ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a USD 45 million funding round led by Granite Asia. Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical industry, significantly… Continue reading AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore